Study points to a strategy for inhibiting hyper-progression of melanoma

Duke Cancer Institute researchers have identified potential biomarkers that predict the likelihood for checkpoint inhibitor drugs to backfire, driving hyper-progression of melanoma cells instead of unleashing the immune system to fight them.

Harris health care agenda swiftly hailed by progressives and reproductive rights groups

WASHINGTON — President Biden’s announcement Sunday that he would be dropping out of the presidential race left Democrats scrambling to rally around the next likely

July 21, 2024

Individual genetic variations and bacterial flora linked to recurrent caries disease

Researchers at Umeå University have for the first time been able to show that individual variation in susceptibility to infection and bacterial flora together explain

February 21, 2024

European regulator says evidence shows no thyroid cancer link to GLP-1s

Current evidence doesn’t support a link between GLP-1 receptor agonists and thyroid cancer, Europe’s drug regulator announced Friday following safety concerns that have been raised

October 28, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.